December 2017—Aushon BioSystems and ABL announced that ABL has adopted the Cira platform for multiplex and ultrasensitive biomarker analysis. ABL will offer this proprietary technology as a new addition to its service offerings in support of pharmaceutical and clinical research clients.
Read More »Home >> Tag Archives: Aushon BioSystems
Patent for microarray printing , 4/17
April 2017—Aushon BioSystems announced U.S. Patent No. 9,527,085, titled “Apparatus and method for dispensing fluid, semi-solid and solid samples,” was issued by the U.S. Patent and Trademark Office for microarray printing of complex biological and chemical fluids.
Read More »Ultrasensitive assays, 7/16
July 2016—Aushon BioSystems has launched the Ciraplex Ultra Ultrasensitive Assays with femtogram/milliliter level detection to address multiple biomarkers in a wide range of therapeutic areas.
Read More »